Obinutuzumab (Gazyva®) en los pacientes no tratados previamente con leucemia linfocítica crónica (LLC)

Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2014
Cargando información sobre las referencias

RECORD STATUS:

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

CITATION:

Breuer J, Joppi R, Poggiani C, Dabrowska M, Zawodnik A. Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL) Vienna: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA).

DSD:

Horizon Scanning in Oncology No. 45. 2014
Epistemonikos ID: b93b7a80c87fcb400d70a69d78732ac2060c9215
First added on: Feb 06, 2015